Journal of Neuroinflammation · 2021 · 27 citations · 42 references
Life SciencesNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeuroimmunologyInflammatory SignalingMetabolic InflammationMicroglia BiologyNeurochemical Signaling PathwaysNeuroinflammationMicroglia ActivationNeuroinflammation ModulationNeuroinflammatory SignalingProinflammatory Mediator ReleaseProinflammatory MediatorsProstaglandin D2 BiosynthesisProstaglandin D2 SignalingRodent Neuroinflammation
Abstract Background Neuroinflammation is a key pathological component of neurodegenerative disease and is characterized by microglial activation and the secretion of proinflammatory mediators. We previously reported that a surge in prostaglandin D 2 (PGD 2 ) production and PGD 2 -induced microglial activation could provoke neuroinflammation. We also reported that a lipid sensor GPR120 (free fatty acid receptor 4), which is expressed in intestine, could be activated by polyunsaturated fatty acids (PUFA), thereby mediating secretion of glucagon-like peptide-1 (GLP-1). Dysfunction of GPR120 results in obesity in both mice and humans. Methods To reveal the relationship between PGD 2 -microglia-provoked neuroinflammation and intestinal PUFA/GPR120 signaling, we investigated neuroinflammation and neuronal function with gene and protein expression, histological, and behavioral analysis in GPR120 knockout (KO) mice. Results In the current study, we discovered notable neuroinflammation (increased PGD 2 production and microglial activation) and neurodegeneration (declines in neurogenesis, hippocampal volume, and cognitive function) in GPR120 KO mice. We also found that Hematopoietic–prostaglandin D synthase (H-PGDS) was expressed in microglia, microglia were activated by PGD 2 , H-PGDS expression was upregulated in GPR120 KO hippocampus, and inhibition of PGD 2 production attenuated this neuroinflammation. GPR120 KO mice exhibited reduced intestinal, plasma, and intracerebral GLP-1 contents. Peripheral administration of a GLP-1 analogue, liraglutide, reduced PGD 2 -microglia-provoked neuroinflammation and further neurodegeneration in GPR120 KO mice. Conclusions Our results suggest that neurological phenotypes in GPR120 KO mice are probably caused by dysfunction of intestinal GPR120. These observations raise the possibility that intestinal GLP-1 secretion, stimulated by intestinal GPR120, may remotely contributed to suppress PGD 2 -microglia-provoked neuroinflammation in the hippocampus.
42
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois, Howard Feldman, Claudia Jacova et al. · The Lancet Neurology · 2014 · 3.3K citations · Full text
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Akira Hirasawa, Keiko Tsumaya, Takeo Awaji et al. · Nature Medicine · 2004 · 1.5K citations
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J. During, Lei Cao, David S. Zuzga et al. · Nature Medicine · 2003 · 844 citations
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human
Atsuhiko Ichimura, Akira Hirasawa, Odile Poulain‐Godefroy et al. · Nature · 2012 · 659 citations · Full text